Form 4: Director James Madden Receives Genpact RSU Grant

Genpact Limited director James C. Madden was granted 9,999 restricted share units as part of the company's incentive plan.

Summary

• Director James C. Madden acquired 9,999 restricted share units (RSUs) on April 23, 2026.
• The grant was issued under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Following this transaction, the director's total beneficial ownership of common shares stands at 73,067.
• The RSUs are subject to continued service requirements.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon the reporting person's continued service to the company.

Future Outlook

The RSUs will fully vest on December 31, 2026, and will be settled in common shares on December 31, 2027, provided the director remains in service.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard corporate governance practices designed to incentivize long-term oversight and strategic alignment in the professional services and IT consulting sector.

Comparison to Industry Standards

• The use of Omnibus Incentive Compensation Plans is a standard practice among S&P 500 and mid-cap technology service firms.
• The vesting schedule of approximately 20 months is consistent with typical retention-based equity awards for board members.

Stakeholder Impact

• Minimal impact on shareholders as this is a standard equity incentive grant.

Next Steps

• Vesting of RSUs on December 31, 2026.
• Settlement of shares on December 31, 2027.

Key Dates

Keywords

Genpact, Form 4, Insider Trading, Director Compensation, Restricted Share Units, G